3-(9-phenyl-carbazol-3-yl)-9H-carbazole | CAS:1060735-14-9

We serve 3-(9-phenyl-carbazol-3-yl)-9H-carbazole CAS:1060735-14-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-(9-phenyl-carbazol-3-yl)-9H-carbazole

Chemical Name:3-(9-phenyl-carbazol-3-yl)-9H-carbazole
CAS.NO:1060735-14-9
Synonyms:3-(9-phenyl-9H-carbazol-3-yl)-9H-carbazole
9-PHENYL-9H,9'H-[3,3']BICARBAZOLYL
PCC
9-phenyl-9H,9'H-3,3'-bicarbazole
9-phenyl-9H,9'H-[3,3']bicarbazolyl
Molecular Formula:C30H20N2
Molecular Weight:408.49300
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates



Contact us for information like 3-(9-phenyl-carbazol-3-yl)-9H-carbazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,9-phenyl-9H,9’H-[3,3′]bicarbazolyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,9-phenyl-9H,9’H-[3,3′]bicarbazolyl Use and application,3-(9-phenyl-carbazol-3-yl)-9H-carbazole technical grade,usp/ep/jp grade.


Related News: On 23 January, Chinese authorities confirmed this nCov can be transmitted between humans, with dozens of medical staff contracting the virus after treating infected patients.2-Pyridinol-1-oxide manufacturer The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients.4-Methylbenzoic acid supplier With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.(S)-N-(2,6-Dimethylphenyl)piperidine-2-carboxamide vendor As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.The first is the API – which is the central ingredient.